Filter
116
Filtered Results: 116
Text search:
S.
Swaminathan
Featured
Recommendations
14
New Publications
16
Language
Document type
No document type
65
Studies & Reports
17
Videos
12
Guidelines
10
Manuals
6
Fact sheets
3
Resource Platforms
2
Infographics
1
Countries / Regions
India
32
Kenya
3
Global
3
Brazil
3
Nepal
2
China
2
Mozambique
2
Asia
2
Latin America and the Carribbean
2
Middle East and North Africa
2
South–East Asia Region
2
Russia
2
Angola
2
Indonesia
2
North Korea
1
Colombia
1
Timor Leste/ East Timor
1
Thailand
1
Ukraine
1
Syria
1
Nigeria
1
Malawi
1
Malaysia
1
Guinea-Bissau
1
Tanzania
1
West and Central Africa
1
Japan
1
Portugal
1
Spain
1
East and Southern Africa
1
Bangladesh
1
South Africa
1
Vietnam
1
Eastern Europe
1
Sri Lanka
1
Ethiopia
1
Bhutan
1
South Sudan
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Guidelines
19
Studies & Reports
8
COVID-19
7
Policies & Guidelines HIV & TB
5
TB
4
Cancer
3
Information, Education and Communication (IEC)
3
HIV & STI
3
x MEDBOX Issue Brief & Annual Reports x
2
Other Cancer diseases
2
Cancer Treatment & Resources
2
Drugs & Medical Equipment
2
Dental & Eye Care
1
Diabetes
1
Breast Cancer
1
Sex. & Repr. Rights
1
Cardiovascular Diseases
1
Medical Devices & Equipment
1
Policies
1
Women & Child Health
1
Community Health
1
Disabilities
1
Leprosy
1
Palliative Care
1
Mental Health
1
Immunization
1
Health Systems
1
Non-communicable Diseases
1
Age & Elderly
1
Disease Prevention & Control
1
Toolboxes
Videos
10
Adults
6
Clinical Guidelines
4
For General Public & Community
4
Vaccine Hesitancy & Myths
4
Detection & Diagnosis
4
Prevention & Control
3
General
3
Information Material &Training
3
Country specific documents
3
SARS-CoV-2 Variants
3
Drug resistant TB
3
Policies & Strategies
2
Childhood TB
2
Prophylaxis
2
TB & Other Vulnerable Populations
2
For Parents & Children
2
Global Impact: Socio-economic, health services, TB & HIV
2
Information for the Public
2
Paediatrics
2
TB/HIV
2
TB/HIV Global
2
Nutrition
2
Research & Access
2
TB/HIV Coinfection
2
Clinical Guidelines
2
SEAR (South-east Asia Region)
2
Surveillance
1
Clinical Aspects, Treatment & Prevention
1
Vaccines & Immunization
1
Country specific
1
HIV surveillance
1
Children & Adolescents
1
South Africa
1
Laboratory
1
Eastern Europe
1
IEC Materials
1
Vaccination
1
Laboratory
1
Country Guidelines
1
Reports
1
Sustainable Development Goals
1
Russia
1
Laboratory
1
Prevention & Preparedness
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Video & Audio
1
For Pregnant Women
1
Training, others
1
Guidelines
1
Communication Material
1
Immunization Guidelines
1
Fair Allocation & Ethical Aspects
1
Self-care
1
Palliative Care
1
Advocacy & Communication
1
Colombia
1
Climate Change General
1
Cancer
1
Videos
1
Heat
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Statistics & Facts
1
Studies & Reports
1
Studies & Reports
1
Overview, Studies & Reports
1
Health Financing Toolbox
1
Prevention & Strategies
1
Studies & Reports
1
Alzheimer's Disease & Dementia
1
Malawi
1
TB & Prisoners
1
HIV and coinfection
1
Antiretroviral Treatment ART
1
TB
1
Epidemiology
1
Eastern Europe & Central Asia
1
Global Burden of Disease
1
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
COVID-19! How Can I Protect Myself and Others?
recommended
This curriculum will help you, and your community, understand the science of the virus that causes COVID-19 and other viruses like it. It will help you to figure out how this virus is impacting or affecting you or may impact you in the future. It will help you to understand the actions that you can ...
El plan de estudios le ayudará a usted, y a su comunidad, a entender la ciencia del virus que causa el COVID-19 y otros virus similares. Le ayudará a descubrir cómo este virus le afecta o puede afectarle en el futuro. Le ayudará a comprender las medidas que puede tomar para mantenerse a salvo y ...
O currículo irá ajudá-lo, a si e à sua comunidade, a compreender a ciência do vírus que causa a COVID-19 e outros vírus como este. Ajudá-lo-á a descobrir como este vírus o está a afectar ou a afectar ou poderá vir a afectá-lo no futuro. Ajudá-lo-á a compreender as acções que pode to...
This Interim Guidance outlines how key public health and social measures needed to reduce the risk of COVID-19 spread and the impact of the disease can be adapted for use in low capacity and humanitarian settings. The recommendations outlined here need to be adjusted to the scale of transmission, co...
Tuberculosis (TB) prevention is essential for reaching the End TB targets in the South-East Asia Region (SEAR) of World Health Organization (WHO)1. The targets of 80% reduction in TB incidence rate and 90% reduction in TB mortality by 2030 (compared to 2015 levels) can be achieved only with addition...
31 Janaury 2021
SCORE for health data technical package. The first global assessment on the status and capacity of health information systems in 133 countries, covering 87% of the global population.
It identifies gaps and provides guidance for investment in areas that can have the greatest impact ...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
manual de aplicación de la OMS
BMC Public Health (2021) 21:299 https://doi.org/10.1186/s12889-021-10296-9
Resource platform
Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-...
Climate Change 2021: The Physical Science Basis. Contribution of Working Group I to the Sixth Assessment Report of the Intergovernmental Panel on Climate Change
Resumo: o que é esta orientação dinâmica?
Pergunta clínica: qual é o papel dos medicamentos na prevenção da COVID-19?
Público-alvo: o público-alvo são os médicos e os tomadores de decisão na área da saúde.
Prática atual: o uso atual de medicamentos para prevenção da COVID-19 é ...
Self-care interventions are among the most promising and exciting new approaches to improve health and well-being, both from a health systems perspective and for people who use these interventions.
The World Health Organization (WHO) uses the following working definition of self-care: Self-care i...
Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA) of antihelmintics is recommended by WHO to elimina...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
Many low- and middle-income countries (LMICs) are undergoing an epidemiological transition. With an improvement in socioeconomic conditions and an aging population, cardiovascular diseases (CVDs), like cardiac arrhythmias, are expected to increase in these countries. However, there are limited studi...
Terminology used to describe the transmission of pathogens through the air varies across scientific disciplines, organizations and the general public. While this has been the case for decades, during the coronavirus disease (COVID-19) pandemic, the terms ‘airborne’, ‘airborne transmission’ a...
